发明授权
US5659040A Process for the preparation of
N-methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulphonamide
失效
制备N-甲基-3-(1-甲基-4-哌啶基)-1H-吲哚-5-乙磺酰胺的方法
- 专利标题: Process for the preparation of N-methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulphonamide
- 专利标题(中): 制备N-甲基-3-(1-甲基-4-哌啶基)-1H-吲哚-5-乙磺酰胺的方法
-
申请号: US600932申请日: 1996-02-29
-
公开(公告)号: US5659040A公开(公告)日: 1997-08-19
- 发明人: Philip Blatcher , Malcolm Carter , Roy Hornby , Martin Richard Owen
- 申请人: Philip Blatcher , Malcolm Carter , Roy Hornby , Martin Richard Owen
- 申请人地址: GB2 London
- 专利权人: Glaxo Group Limited
- 当前专利权人: Glaxo Group Limited
- 当前专利权人地址: GB2 London
- 优先权: GBX9320115 19930929
- 主分类号: B01J23/38
- IPC分类号: B01J23/38 ; B01J25/02 ; B01J31/04 ; B01J31/12 ; C07B35/02 ; C07B61/00 ; C07D401/04 ; C07D403/04 ; C07D211/02
摘要:
A process for the preparation of the compound of formula (I) ##STR1## or a salt thereof which comprises reducing the compound of formula (II) ##STR2## or a salt thereof. The novel intermediate of formula (II) and processes for preparing it are also described.